Followers | 261 |
Posts | 19732 |
Boards Moderated | 0 |
Alias Born | 10/03/2004 |
![](https://investorshub.advfn.com/uicon/45965.png?cb=1637315758)
Wednesday, February 08, 2006 11:08:06 PM
1) Vietnam because that is where the first cases were confirmed and they have already isolated and cultured quantities of the virus. The deal was in the works before cases were confirmed outside that area, with the exception of China.
(2) Not China for two reasons: (i) China wants to do the research themselves and is reluctant to part with the virus. (ii) China makes deals and then steals technology. They would insist on the tests being done on their own soil if they supplied the virus. (iii) Undoubtedly China would use the deadly nature of the virus as rationale for disallowing testing of their virus elsewhere. Naturally, they would refuse to allow such a contagion to leave the country. (iv) Research would be completed under their inspection, in their labs, and with their technicians [Read: steal the technology by reverse-engineering the test samples].
(3) Vietnam became desperate enough to agree to use Tamiflu. They then found that even when they used the correct dosage protocol, they still had patients die. [Do nothing and Bird Flu damage takes 2 months to heal. Take Tamiflu and the symptoms only last 60 days.)
(4) Vietnam is a non-aligned country, which means that they are currently relatively free of outside political pressure and influence. The governments of the USA, France, Great Britain, China, Germany and Russia all have limited influence in Vietnam. Therefore they are free to choose "non-conventional" approaches as opposed to more conventional WHO approved approaches [Read: vaccinate, quarantine and sterilize].
Recent NNVC News
- NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • InvestorsHub NewsWire • 05/02/2024 02:07:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:53:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 09:55:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:44:48 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/04/2023 09:08:49 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/13/2023 08:30:41 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/28/2023 08:44:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/01/2023 08:46:45 PM
- Clinical Trial of Broad-Spectrum Antiviral Drug NV-CoV-2 is Progressing Well, Says NanoViricides - NV-CoV-2 is Positioned to Fulfill Many Unmet Medical Needs • InvestorsHub NewsWire • 07/06/2023 03:16:37 PM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM
Element79 Gold Corp Files for OTCQB Uplisting, Provides Financial Update • ELEM • Jun 11, 2024 9:25 AM